• Blood Test Ably Identifies Ovarian Cancer Prior to Surgery, Clinical Trial Planned
  • Scientists Discover Enzyme with Key Role in Aggressive Ovarian Cancers
  • MDNA55-Interferons Combo Kills Cancer Cells, Extends Lifespan of Mice with Ovarian Cancer, Study Reports
  • Zejula-Keytruda Trial Results Warrant Further Investigation for Recurrent OC
  • Lynparza Approved in Japan as First-Line Maintenance Therapy for Advanced OC
  • New Blood Test May Improve Ovarian Cancer Diagnosis, Study Suggests
  • Testing for Multiple Biomarkers at a Time Can Increase Early Detection of OC
  • PARP Inhibitors Used in ‘One-two Punch’ Strategy to Kill OC Cells in Mouse Models, Study Shows
  • FDA Grants Priority Review to GSK’s Zejula for Late Stage Ovarian Cancer
  • Researchers Work to Create Screening Tool for Early or Pre-cancerous OC
  • Lynparza Approved in Europe as Initial Maintenance Therapy for Some OC
  • Sentinel Node Biopsy Feasible to Determine Spread of Early-stage OC